NLRP3 and cervical squamous intraepithelial neoplasia: A proton-pump inhibitor called omeprazole, which should only affect the NLRP3 inflammasome activation portion of this signalling axis, was effective in ameliorating CIN and decreasing TLR4/NF-κB/NLRP3 levels.